Home » Study: Capecitabine Combination Therapy Reduces Early Breast Cancer Recurrence
Study: Capecitabine Combination Therapy Reduces Early Breast Cancer Recurrence
An analysis conducted by the Finnish Breast Cancer Group and published in The Lancet Oncology shows women at intermediate to high-risk of early
breast cancer recurrence who received capecitabine as part of their chemotherapy regimen had a 34 percent reduction in the risk of the disease returning
or death, compared with those taking the chemotherapy combination regimen without capecitabine.
Yahoo! Finance
Yahoo! Finance
Upcoming Events
-
07May
-
14May
-
30May